Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Promyelocytic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00002701
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 750
Testing effectiveness (Phase 2)Study completedNCT00021242
What this trial is testing

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 12
Testing effectiveness (Phase 2)Ended earlyNCT00907582
What this trial is testing

ASCT for Relapsed APL After Molecular Remission

Who this might be right for
Acute Promyelocytic LeukemiaRelapse
Shanghai Jiao Tong University School of Medicine 5
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)UnknownNCT04175587
What this trial is testing

Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL

Who this might be right for
Acute Promyelocytic Leukaemia
Peking University People's Hospital 109
Testing effectiveness (Phase 2)Study completedNCT00413166
What this trial is testing

All-trans Retinoic Acid, and Arsenic +/- Idarubicin

Who this might be right for
Acute Promyelocytic Leukemia
M.D. Anderson Cancer Center 78
Large-scale testing (Phase 3)Looking for participantsNCT07504458
What this trial is testing

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)Acute Promyelocytic LeukaemiaAcute Promyelocytic Leukemia With PML-RARA+2 more
Quetzal Therapeutics 150
Early research (Phase 1)Study completedNCT00020111
What this trial is testing

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Post-approval studies (Phase 4)UnknownNCT00196768
What this trial is testing

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Who this might be right for
Relapsed Acute Promyelocytic LeukemiaRefractory Acute Promyelocytic Leukemia
German AML Cooperative Group 30
Testing effectiveness (Phase 2)Study completedNCT00005962
What this trial is testing

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00305773
What this trial is testing

Vorinostat in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Erythroid Leukemia (M6)Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+15 more
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00022451
What this trial is testing

Tipifarnib in Treating Young Patients With Refractory Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Active Not RecruitingNCT02339740
What this trial is testing

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Children's Oncology Group 158
Testing effectiveness (Phase 2)Study completedNCT00016159
What this trial is testing

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01445080
What this trial is testing

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Blastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more
National Cancer Institute (NCI) 70
Early research (Phase 1)Study completedNCT00083070
What this trial is testing

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 16
Large-scale testing (Phase 3)UnknownNCT01226303
What this trial is testing

Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica 300
Testing effectiveness (Phase 2)Looking for participantsNCT01409161
What this trial is testing

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center 151
Early research (Phase 1)Ended earlyNCT00852709
What this trial is testing

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)UnknownNCT00517712
What this trial is testing

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Christian Medical College, Vellore, India 400
Next Page